Stockreport

Is CRISPR Therapeutics (CRSP) Attractive After Recent Gene Editing Progress And Mixed Returns? [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF The stock has seen a mixed return profile, with a 0.1% move over the past week, a 6.5% decline over 30 days, a flat 0.1% year to date, a 35.7% return over 1 year, 7.8% [Read more]